Clinical Trials Directory

Trials / Completed

CompletedNCT00654303

OLE Study to Evaluate Safety / Efficacy of ZD4522

ZD4522 Long Term Extension Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
3,500 (estimated)
Sponsor
AstraZeneca · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the long term safety of Crestor.

Conditions

Interventions

TypeNameDescription
DRUGRosuvastatin

Timeline

Start date
1999-08-01
Completion
2005-02-01
First posted
2008-04-07
Last updated
2009-03-16

Source: ClinicalTrials.gov record NCT00654303. Inclusion in this directory is not an endorsement.

OLE Study to Evaluate Safety / Efficacy of ZD4522 (NCT00654303) · Clinical Trials Directory